Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

NewLink Genetics Corporation (NLNK)

-NasdaqGM
21.76 0.78(3.72%) Jul 29, 4:00PM EDT
Prev Close:20.98
Open:21.03
Bid:21.78 x 200
Ask:22.74 x 100
1y Target Est:36.25
Beta:-1.07
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:21.01 - 21.96
52wk Range:15.61 - 53.48
Volume:148,510
Avg Vol (3m):323,113
Market Cap:606.54M
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NLNK

Comparison

Symbol% ChgMkt Cap
NLNKUp 3.72%606.54M
LLY67.57B
TEVA46.21B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):519.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.74
Quarterly EPS Est (Jun-14) :-0.42
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products to enhance treatment options for patients with cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback